[{"Assets_0_Q1_USD":461502000.0,"CommonStockSharesOutstanding_0_Q1_shares":123395113.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-29090000.0,"NetIncomeLoss_1_Q1_USD":-36950000.0,"StockholdersEquity_0_Q1_USD":434932000.0,"Ticker":"IOVA","CIK":"1425205","name":"IOVANCE BIOTHERAPEUTICS, INC.","OfficialName":"Iovance Biotherapeutics Inc. Common Stock","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2593277297.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190507"}]